ID27280A - INHIBITORS OF PHOSPHOLIPASE ENZIMTS - Google Patents
INHIBITORS OF PHOSPHOLIPASE ENZIMTSInfo
- Publication number
- ID27280A ID27280A IDW20001594A ID20001594A ID27280A ID 27280 A ID27280 A ID 27280A ID W20001594 A IDW20001594 A ID W20001594A ID 20001594 A ID20001594 A ID 20001594A ID 27280 A ID27280 A ID 27280A
- Authority
- ID
- Indonesia
- Prior art keywords
- enzimts
- phospholipase
- inhibitors
- phospholipase enzimts
- Prior art date
Links
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 title 1
- 102000015439 Phospholipases Human genes 0.000 title 1
- 108010064785 Phospholipases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3006298A | 1998-02-25 | 1998-02-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID27280A true ID27280A (en) | 2001-03-22 |
Family
ID=21852314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20001594A ID27280A (en) | 1998-02-25 | 1999-02-24 | INHIBITORS OF PHOSPHOLIPASE ENZIMTS |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1056719A2 (en) |
| JP (1) | JP2002504539A (en) |
| KR (1) | KR20010041343A (en) |
| CN (1) | CN1299347A (en) |
| AU (1) | AU2782699A (en) |
| BG (1) | BG104780A (en) |
| BR (1) | BR9908280A (en) |
| CA (1) | CA2322161A1 (en) |
| EA (1) | EA200000868A1 (en) |
| EE (1) | EE200000486A (en) |
| HR (1) | HRP20000552A2 (en) |
| HU (1) | HUP0100757A3 (en) |
| ID (1) | ID27280A (en) |
| IL (1) | IL137718A0 (en) |
| NO (1) | NO20004220L (en) |
| PL (1) | PL342995A1 (en) |
| SK (1) | SK12742000A3 (en) |
| TR (1) | TR200002446T2 (en) |
| WO (1) | WO1999043651A2 (en) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4591800A (en) * | 1999-05-05 | 2000-11-21 | Aventis Pharma Limited | Ureas as cell adhesion modulators |
| CA2415742A1 (en) | 2000-07-25 | 2002-01-31 | Merck & Co., Inc. | N-substituted indoles useful in the treatment of diabetes |
| WO2002060438A1 (en) | 2001-01-29 | 2002-08-08 | 3-Dimensional Pharmaceuticals, Inc. | Substituted indoles and their use as integrin antagonists |
| US6608196B2 (en) | 2001-05-03 | 2003-08-19 | Galileo Pharmaceuticals, Inc. | Process for solid supported synthesis of pyruvate-derived compounds |
| US6916850B2 (en) | 2001-05-03 | 2005-07-12 | Galileo Pharmaceuticals, Inc. | Pyruvate derivatives |
| US7291639B2 (en) | 2001-06-20 | 2007-11-06 | Wyeth | Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| US7074817B2 (en) | 2001-06-20 | 2006-07-11 | Wyeth | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| US7189751B2 (en) * | 2001-06-25 | 2007-03-13 | Nippon Soda Co., Ltd. | Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| US6984735B2 (en) | 2001-12-03 | 2006-01-10 | Wyeth | Process for making an aldehyde |
| EP1892239B1 (en) * | 2001-12-03 | 2013-02-20 | Wyeth LLC | Inhibitors of cytosolic phospholipase A2 |
| US7713964B2 (en) | 2001-12-03 | 2010-05-11 | Wyeth Llc | Methods for treating asthmatic conditions |
| US7101875B2 (en) | 2001-12-03 | 2006-09-05 | Wyeth | Methods for treating arthritic disorders |
| US6635771B2 (en) | 2001-12-03 | 2003-10-21 | Wyeth | N-benzhydryl indole compounds |
| HUP0402577A3 (en) * | 2001-12-03 | 2011-05-30 | Wyeth Corp | Indole derivatives as inhibitors of cytosolic phospholipase a2, process for producing them and pharmaceutical compositions containing them |
| US6797708B2 (en) | 2001-12-03 | 2004-09-28 | Wyeth | Inhibitors of cytosolic phospholipase A2 |
| US7605156B2 (en) | 2001-12-03 | 2009-10-20 | Wyeth | Methods for the use of inhibitors of cytosolic phospholipase A2 |
| AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
| CA2495943C (en) | 2002-08-29 | 2009-07-21 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
| WO2004019869A2 (en) | 2002-08-29 | 2004-03-11 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
| HRP20050396A2 (en) | 2002-11-07 | 2005-06-30 | Akzo Nobel N.V. | Indoles useful in the treatment of androgen-receptor related diseases |
| EP1569899B1 (en) | 2002-12-10 | 2006-06-28 | Wyeth | Substituted 3-alkyl- and 3-arylalkyl-1h-indol-1-yl-acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| US7078429B2 (en) | 2002-12-10 | 2006-07-18 | Wyeth | Substituted 3-carbonyl-1H-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
| WO2004052856A1 (en) | 2002-12-10 | 2004-06-24 | Wyeth | Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| WO2004052854A2 (en) | 2002-12-10 | 2004-06-24 | Wyeth | Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| TW200510305A (en) * | 2003-07-25 | 2005-03-16 | Wyeth Corp | Process for the preparation of CPLA2 inhibitors |
| US7411083B2 (en) | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
| US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
| US7582773B2 (en) | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
| US7534894B2 (en) | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
| US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
| US7342039B2 (en) | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
| US7163954B2 (en) | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
| US7141592B2 (en) | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
| US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
| US7446201B2 (en) | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
| US7420083B2 (en) | 2003-09-25 | 2008-09-02 | Wyeth | Substituted aryloximes |
| US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
| US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
| GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| TW200602317A (en) | 2004-04-23 | 2006-01-16 | Akzo Nobel Nv | Novel androgens |
| BRPI0512252A (en) | 2004-06-18 | 2008-02-19 | Biolipox Ab | compound or a pharmaceutically acceptable salt thereof, pharmaceutical formulation, use of a compound, method of treating a disease, combined product, and process for preparing a compound |
| WO2006023866A2 (en) | 2004-08-23 | 2006-03-02 | Wyeth | Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 |
| WO2006023864A1 (en) | 2004-08-23 | 2006-03-02 | Wyeth | Pyrrolo-naphthyl acids as pai-1 inhibitors |
| MX2007002178A (en) | 2004-08-23 | 2007-04-02 | Wyeth Corp | Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases. |
| KR100912146B1 (en) * | 2004-10-27 | 2009-08-14 | 에프. 호프만-라 로슈 아게 | Indole or benzimidazole derivatives |
| WO2006077366A1 (en) | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflammation |
| US7777040B2 (en) | 2005-05-03 | 2010-08-17 | Cgi Pharmaceuticals, Inc. | Certain substituted ureas, as modulators of kinase activity |
| TW200718687A (en) | 2005-05-27 | 2007-05-16 | Wyeth Corp | Inhibitors of cytosolic phospholipase A2 |
| US7683091B2 (en) | 2005-08-17 | 2010-03-23 | Wyeth | Substituted indoles and methods of their use |
| EP2240444A1 (en) | 2008-01-22 | 2010-10-20 | Oxagen Limited | Compounds having crth2 antagonist activity |
| AR072297A1 (en) | 2008-06-27 | 2010-08-18 | Novartis Ag | DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE. |
| EP2448938B9 (en) | 2009-06-29 | 2015-06-10 | Incyte Corporation | Pyrimidinones as pi3k inhibitors |
| WO2011075643A1 (en) | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted heteroaryl fused derivatives as pi3k inhibitors |
| EP2558463A1 (en) | 2010-04-14 | 2013-02-20 | Incyte Corporation | Fused derivatives as i3 inhibitors |
| US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
| JP5961187B2 (en) | 2010-12-20 | 2016-08-02 | インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | N- (1- (substituted phenyl) ethyl) -9H-purin-6-amine as a PI3K inhibitor |
| US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
| US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
| MX389479B (en) | 2011-09-02 | 2025-03-20 | Incyte Holdings Corp | HETEROCYCLYLAMINES AS INHIBITORS OF PHOSPHOINOSITIDE 3-KINASES (PI3K) |
| AR090548A1 (en) | 2012-04-02 | 2014-11-19 | Incyte Corp | BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS |
| CN104619693B (en) | 2012-07-17 | 2019-08-13 | 葛兰素史克知识产权第二有限公司 | Indole nitriles as selective androgen receptor modulators |
| GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
| US10077277B2 (en) | 2014-06-11 | 2018-09-18 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
| SG10201912302VA (en) | 2015-02-27 | 2020-02-27 | Incyte Corp | Salts of pi3k inhibitor and processes for their preparation |
| WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
| IL278889B2 (en) | 2018-06-01 | 2025-11-01 | Incyte Corp | Dosage regimen for the treatment of PI3K-related disorders |
| LT3860998T (en) | 2018-10-05 | 2024-06-25 | Annapurna Bio Inc. | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE314373B (en) * | 1966-04-12 | 1969-09-08 | Sumitomo Chemical Co | |
| FR1492929A (en) * | 1966-05-11 | 1967-08-25 | Roussel Uclaf | Novel substituted 1- (omega-carboxyalkyl) indoles and method of preparation |
| US3505354A (en) * | 1967-05-18 | 1970-04-07 | Geigy Chem Corp | 2-methyl-3-p-halobenzoylindole-n-aliphatic acids |
| DE1816335A1 (en) * | 1968-12-21 | 1970-07-09 | Thiemann Gmbh Chem Pharm Fabri | 2-methyl-5-alkoxy-3-acyl-indole-1-acetic - acid and esters thereof |
| US4894386A (en) * | 1987-04-15 | 1990-01-16 | Ici Americas Inc. | Aliphatic carboxamides |
| IE63043B1 (en) * | 1988-04-13 | 1995-03-22 | Ici America Inc | Cyclic amides |
| US5420289A (en) * | 1989-10-27 | 1995-05-30 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
| US5290798A (en) * | 1991-09-30 | 1994-03-01 | Merck Frosst Canada, Inc. | (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| AU672599B2 (en) * | 1992-05-13 | 1996-10-10 | Syntex (U.S.A.) Inc. | Substituted indoles and azaindoles as angiotensin II antagonists |
| IL109311A0 (en) * | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
| DE4338770A1 (en) * | 1993-11-12 | 1995-05-18 | Matthias Dr Lehr | Indole-2-alkanoic acids and their derivatives as inhibitors of phospholipase A¶2¶ |
| CA2262847C (en) * | 1996-08-01 | 2007-06-05 | Merckle Gmbh | Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |
| JP2000516958A (en) * | 1996-08-26 | 2000-12-19 | ジェネティックス・インスチチュート・インコーポレーテッド | Phospholipase enzyme inhibitors |
-
1999
- 1999-02-24 ID IDW20001594A patent/ID27280A/en unknown
- 1999-02-24 CN CN99805385A patent/CN1299347A/en active Pending
- 1999-02-24 EA EA200000868A patent/EA200000868A1/en unknown
- 1999-02-24 TR TR2000/02446T patent/TR200002446T2/en unknown
- 1999-02-24 SK SK1274-2000A patent/SK12742000A3/en unknown
- 1999-02-24 HR HR20000552A patent/HRP20000552A2/en not_active Application Discontinuation
- 1999-02-24 IL IL13771899A patent/IL137718A0/en unknown
- 1999-02-24 HU HU0100757A patent/HUP0100757A3/en unknown
- 1999-02-24 CA CA002322161A patent/CA2322161A1/en not_active Abandoned
- 1999-02-24 JP JP2000533409A patent/JP2002504539A/en not_active Withdrawn
- 1999-02-24 AU AU27826/99A patent/AU2782699A/en not_active Abandoned
- 1999-02-24 KR KR1020007009456A patent/KR20010041343A/en not_active Withdrawn
- 1999-02-24 WO PCT/US1999/003899 patent/WO1999043651A2/en not_active Ceased
- 1999-02-24 EP EP99908379A patent/EP1056719A2/en not_active Withdrawn
- 1999-02-24 PL PL99342995A patent/PL342995A1/en unknown
- 1999-02-24 EE EEP200000486A patent/EE200000486A/en unknown
- 1999-02-24 BR BR9908280-2A patent/BR9908280A/en not_active IP Right Cessation
-
2000
- 2000-08-23 NO NO20004220A patent/NO20004220L/en unknown
- 2000-09-19 BG BG104780A patent/BG104780A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1056719A2 (en) | 2000-12-06 |
| NO20004220D0 (en) | 2000-08-23 |
| KR20010041343A (en) | 2001-05-15 |
| BG104780A (en) | 2001-10-31 |
| PL342995A1 (en) | 2001-07-16 |
| AU2782699A (en) | 1999-09-15 |
| JP2002504539A (en) | 2002-02-12 |
| EA200000868A1 (en) | 2001-04-23 |
| IL137718A0 (en) | 2001-10-31 |
| HRP20000552A2 (en) | 2001-04-30 |
| CA2322161A1 (en) | 1999-09-02 |
| WO1999043651A2 (en) | 1999-09-02 |
| HUP0100757A3 (en) | 2001-11-28 |
| TR200002446T2 (en) | 2000-12-21 |
| WO1999043651A3 (en) | 1999-12-16 |
| NO20004220L (en) | 2000-10-05 |
| HUP0100757A1 (en) | 2001-08-28 |
| SK12742000A3 (en) | 2001-05-10 |
| EE200000486A (en) | 2002-02-15 |
| CN1299347A (en) | 2001-06-13 |
| BR9908280A (en) | 2000-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID26250A (en) | INHIBITORS FROM PHOSPHOLIPASE ENZIMTS | |
| NO20004217D0 (en) | Inhibitors of phospholipase A2 | |
| NO20004220L (en) | Inhibitors of phospholipase enzymes | |
| DK1114051T3 (en) | Inhibitors of p38 | |
| AR028253A1 (en) | INHIBITORS OF THE GLUCOGENO FOSFORILASA | |
| PT1086076E (en) | SULFONAMIDE INHIBITORS OF ASPARTIL PROTEASE | |
| ID29380A (en) | CONSTITUATION OF ACID GAS GAS FROM GAS | |
| ATE245142T1 (en) | NO-SYNTHASE INHIBITORS | |
| ID27092A (en) | MAKING OF ANHYDRIDAL FTALATES | |
| DK2253620T3 (en) | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN-TYROSINKINASE INHIBITORS | |
| NO20004550D0 (en) | Enzyme inhibitors | |
| DK1027332T3 (en) | New lactametalloprotease inhibitors | |
| DK0958287T3 (en) | Sulfamidmetalloprotease inhibitors | |
| PT927183E (en) | SPIROCYLIC INHIBITORS OF METALOPROTEASES | |
| NO20012960D0 (en) | Farnesyl inhibitors | |
| PT1047450E (en) | ACE INHIBITOR COMBINATIONS - MMP INHIBITOR | |
| DE60224707D1 (en) | INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 | |
| FR2816843B1 (en) | INHIBITORS OF ENZYME 5 ALPHA-REDUCTASE | |
| ATE252547T1 (en) | MATRIXMETALLOPROTEINASE INHIBITORS | |
| ID28032A (en) | TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2 | |
| DE69903319D1 (en) | FKBP INHIBITORS | |
| EE200100084A (en) | New pharmaceutical uses of NOS inhibitors | |
| NO993161D0 (en) | cyclooxygenase inhibitors | |
| EP1025851A4 (en) | ALPHA-GLUCOSIDASE INHIBITOR | |
| NO20006314D0 (en) | Prenyltransferase inhibitors |